Growth Metrics

Steris (STE) Cash from Financing Activities (2018 - 2025)

Steris has reported Cash from Financing Activities over the past 8 years, most recently at -$98.0 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 54.29% year-over-year to -$98.0 million; the TTM value through Dec 2025 reached -$648.4 million, up 57.85%, while the annual FY2025 figure was -$1.6 billion, 1745.8% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$98.0 million at Steris, up from -$159.2 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $818.8 million in Q2 2021 and troughed at -$998.9 million in Q2 2024.
  • A 5-year average of -$130.4 million and a median of -$179.5 million in 2024 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 945.22% in 2021 and later soared 1146.13% in 2023.
  • Year by year, Cash from Financing Activities stood at -$189.3 million in 2021, then soared by 36.38% to -$120.4 million in 2022, then plummeted by 64.43% to -$198.0 million in 2023, then dropped by 8.29% to -$214.4 million in 2024, then skyrocketed by 54.29% to -$98.0 million in 2025.
  • Business Quant data shows Cash from Financing Activities for STE at -$98.0 million in Q4 2025, -$159.2 million in Q3 2025, and -$213.1 million in Q2 2025.